Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2− Metastatic Breast Cancer

被引：0
|
作者：
Annie Guérin
Debbie Goldschmidt
Tania Small
Patrick Gagnon-Sanschagrin
Hela Romdhani
Genevieve Gauthier
Sneha Kelkar
Eric Q. Wu
Polly Niravath
Anand A. Dalal
机构：
[1] Analysis Group,
[2] Inc.,undefined
[3] Analysis Group,undefined
[4] Inc.,undefined
[5] Novartis Pharmaceuticals Corporation,undefined
[6] Analysis Group,undefined
[7] Inc.,undefined
[8] Houston Methodist Hospital,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
CDK4/6 inhibitor; HR+/HER2−; Metastatic breast cancer; Monitoring; Oncology; Post-menopausal;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1251 / 1264
页数：13
相关论文
共 50 条
  • [1] Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2-Metastatic Breast Cancer
    Guerin, Annie
    Goldschmidt, Debbie
    Small, Tania
    Gagnon-Sanschagrin, Patrick
    Romdhani, Hela
    Gauthier, Genevieve
    Kelkar, Sneha
    Wu, Eric Q.
    Niravath, Polly
    Dalal, Anand A.
    ADVANCES IN THERAPY, 2018, 35 (08) : 1251 - 1264
  • [2] Ribociclib for post-menopausal women with HR+/HER2-advanced or metastatic breast cancer
    Zangardi, Mark L.
    Spring, Laura M.
    Blouin, Gayle C.
    Bardia, Aditya
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (11) : 1169 - 1176
  • [3] Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2− Advanced Breast Cancer
    Anand A. Dalal
    Geneviève Gauthier
    Patrick Gagnon-Sanschagrin
    Rebecca Burne
    Annie Guérin
    Polly Niravath
    Tania Small
    Advances in Therapy, 2018, 35 : 1356 - 1367
  • [4] Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2-metastatic breast cancer: a retrospective US claims study
    Guerin, Annie
    Hao, Yanni
    Tang, Derek
    Peeples, Miranda
    Fang, Anna
    Kageleiry, Andrew
    Koo, Valerie
    Li, Nanxin
    Wu, Eric Q.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1189 - 1196
  • [5] Treatment patterns and duration in post-menopausal women with HR+/HER2-metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004-2010)
    Macalalad, Alexander R.
    Hao, Yanni
    Lin, Peggy L.
    Signorovitch, James E.
    Wu, Eric Q.
    Ohashi, Erika
    Zhou, Zhou
    Kelley, Caroline
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (02) : 263 - 273
  • [6] Current Treatment Patterns Among Postmenopausal Women with HR+/HER2− Metastatic Breast Cancer in US Community Oncology Practices: An Observational Study
    Deborah Goldschmidt
    Anand A. Dalal
    Hela Romdhani
    Sneha Kelkar
    Annie Guerin
    Genevieve Gauthier
    Eric Q. Wu
    Polly Niravath
    Tania Small
    Advances in Therapy, 2018, 35 : 482 - 493
  • [7] First-line treatment disruption among post-menopausal women with HR+/HER2-breast cancer: a retrospective US claims study
    Tang, Derek H.
    Li, Nanxin
    Du, Ella X.
    Peeples, Miranda
    Chu, Lihao
    Xie, Jipan
    Barghout, Victoria
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (12) : 2137 - 2143
  • [8] Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women
    Geneviève Gauthier
    Patrick Gagnon-Sanschagrin
    Annie Guérin
    Rebecca Burne
    Tania Small
    Polly Niravath
    Anand A. Dalal
    Advances in Therapy, 2018, 35 : 503 - 514
  • [9] Economic Burden of HR+/HER2-Metastatic Breast Cancer Among Adult Premenopausal Women
    Gauthier, Genevieve
    Gagnon-Sanschagrin, Patrick
    Guerin, Annie
    Burne, Rebecca
    Small, Tania
    Niravath, Polly
    Dalal, Anand A.
    ADVANCES IN THERAPY, 2018, 35 (04) : 503 - 514
  • [10] Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2-advanced or metastatic breast cancer
    Mistry, Rohit
    Suri, Gaurav
    Young, Kate
    Hettle, Robert
    May, Jessica R.
    Brixner, Diana
    Oderda, Gary
    Biskupiak, Joseph
    Tang, Derek
    Bhattacharyya, Devarshi
    Bhattacharyya, Subrata
    Mishra, Dinesh
    Dalal, Anand A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (12) : 2143 - 2150
12345